Barclays Increases Molina Healthcare (NYSE:MOH) Price Target to $372.00

Molina Healthcare (NYSE:MOH) had its price objective upped by Barclays from $359.00 to $372.00 in a research report issued on Friday, Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Barclays‘s target price indicates a potential upside of 14.27% from the company’s current price.

Several other brokerages have also recently issued reports on MOH. Stephens reiterated an “equal weight” rating and set a $320.00 price target on shares of Molina Healthcare in a research report on Thursday, July 25th. StockNews.com raised Molina Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, October 18th. Jefferies Financial Group dropped their price target on Molina Healthcare from $354.00 to $297.00 and set a “hold” rating on the stock in a research report on Wednesday, July 24th. Truist Financial decreased their price objective on Molina Healthcare from $440.00 to $400.00 and set a “buy” rating for the company in a report on Monday, July 15th. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on shares of Molina Healthcare from $354.00 to $353.00 and set a “hold” rating on the stock in a report on Monday, July 29th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $367.00.

Molina Healthcare Price Performance

Shares of Molina Healthcare stock opened at $325.54 on Friday. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.49. The company’s fifty day simple moving average is $335.23 and its two-hundred day simple moving average is $329.72. The firm has a market cap of $19.08 billion, a PE ratio of 17.84, a price-to-earnings-growth ratio of 0.99 and a beta of 0.58. Molina Healthcare has a 12-month low of $272.69 and a 12-month high of $423.92.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Wednesday, October 23rd. The company reported $6.01 earnings per share for the quarter, topping analysts’ consensus estimates of $5.96 by $0.05. The firm had revenue of $10.34 billion for the quarter, compared to analyst estimates of $9.92 billion. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. The business’s quarterly revenue was up 21.0% compared to the same quarter last year. During the same period last year, the company earned $5.05 EPS. As a group, equities analysts expect that Molina Healthcare will post 23.5 EPS for the current year.

Insider Transactions at Molina Healthcare

In related news, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total transaction of $339,210.00. Following the completion of the sale, the director now owns 18,025 shares of the company’s stock, valued at $6,114,260.25. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the sale, the director now directly owns 18,025 shares of the company’s stock, valued at $6,114,260.25. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Maurice Hebert sold 393 shares of the business’s stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $346.52, for a total value of $136,182.36. Following the completion of the transaction, the chief accounting officer now directly owns 9,473 shares of the company’s stock, valued at approximately $3,282,583.96. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.10% of the company’s stock.

Institutional Investors Weigh In On Molina Healthcare

A number of large investors have recently added to or reduced their stakes in MOH. Wealth Enhancement Advisory Services LLC boosted its stake in shares of Molina Healthcare by 35.9% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 2,734 shares of the company’s stock worth $1,123,000 after buying an additional 722 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of Molina Healthcare by 139.0% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 64,496 shares of the company’s stock valued at $26,497,000 after purchasing an additional 37,509 shares during the period. First Trust Direct Indexing L.P. increased its position in shares of Molina Healthcare by 11.0% during the 1st quarter. First Trust Direct Indexing L.P. now owns 2,767 shares of the company’s stock valued at $1,137,000 after purchasing an additional 275 shares during the last quarter. HB Wealth Management LLC bought a new position in shares of Molina Healthcare in the 1st quarter worth approximately $244,000. Finally, JLB & Associates Inc. boosted its holdings in shares of Molina Healthcare by 48.6% in the first quarter. JLB & Associates Inc. now owns 9,003 shares of the company’s stock worth $3,699,000 after buying an additional 2,944 shares during the last quarter. Institutional investors own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.